source
- Supreme Court unanimously backs Hikma's skinny label fish oil genericThe U.S. Supreme Court issued a unanimous decision favoring Hikma Pharmaceuticals in a dispute over its skinny label version of a prescription-strength fish oil product. The court ruled that Hikma…
- Parabilis Medicines targets over $400 million in Nasdaq IPO to fund peptide pipelineParabilis Medicines, a peptide-focused biotech led by former Johnson & Johnson R&D head Mathai Mammen, announced plans for a Nasdaq initial public offering. The company aims to raise more than $40…